{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T21:09:17Z","timestamp":1788988157070,"version":"build-2803163510"},"reference-count":83,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01EB032349"],"award-info":[{"award-number":["R01EB032349"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R35GM142770"],"award-info":[{"award-number":["R35GM142770"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100001395","name":"Wisconsin Alumni Research Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100001395","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100014080","name":"Division of Graduate Studies, University of Oregon","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100014080","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007015","name":"University of Wisconsin-Madison","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007015","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000001","name":"National Science Foundation","doi-asserted-by":"publisher","award":["2137424"],"award-info":[{"award-number":["2137424"]}],"id":[{"id":"10.13039\/100000001","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Current Opinion in Chemical Biology"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1016\/j.cbpa.2026.102754","type":"journal-article","created":{"date-parts":[[2026,8,28]],"date-time":"2026-08-28T12:50:27Z","timestamp":1787921427000},"page":"102754","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Recent advancements in radiometal chelation for targeted applications in nuclear medicine"],"prefix":"10.1016","volume":"94","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0948-2312","authenticated-orcid":false,"given":"Edith K.","family":"Amason","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Owen M.","family":"Glaser","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4186-6586","authenticated-orcid":false,"given":"Eszter","family":"Boros","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.cbpa.2026.102754_bib1","doi-asserted-by":"crossref","first-page":"2732","DOI":"10.1039\/c3cc38507h","article-title":"The ubiquitous DOTA and its derivatives: the impact of 1,4,7,10-tetraazacyclododecane-1,4,7,10-tetraacetic acid on biomedical imaging","volume":"49","author":"Stasiuk","year":"2013","journal-title":"Chem Commun"},{"key":"10.1016\/j.cbpa.2026.102754_bib2","doi-asserted-by":"crossref","first-page":"2845","DOI":"10.1021\/ic0353007","article-title":"Solution dynamics and stability of Lanthanide(III) (S)-2-(p-Nitrobenzyl)DOTA complexes","volume":"43","author":"Woods","year":"2004","journal-title":"Inorg Chem"},{"key":"10.1016\/j.cbpa.2026.102754_bib3","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1021\/bc00005a008","article-title":"Synthesis and evaluation of two new bifunctional carboxymethylated tetraazamacrocyclic chelating agents for protein labeling with indium-111","volume":"1","author":"Ruser","year":"1990","journal-title":"Bioconjug Chem"},{"key":"10.1016\/j.cbpa.2026.102754_bib4","doi-asserted-by":"crossref","first-page":"20621","DOI":"10.1021\/acs.inorgchem.3c00621","article-title":"Is smaller better? Cu2+\/Cu+ coordination chemistry and Copper-64 radiochemical investigation of a 1,4,7-Triazacyclononane-Based sulfur-rich chelator","volume":"62","author":"Tosato","year":"2023","journal-title":"Inorg Chem"},{"issue":"Suppl. 2","key":"10.1016\/j.cbpa.2026.102754_bib5","first-page":"1454","article-title":"An initial investigation of radiolabeling with higher oxidation states of astatine-211. Evaluation of chelation with DOTA and NOTA","volume":"51","author":"Wilbur","year":"2010","journal-title":"J Nucl Med"},{"key":"10.1016\/j.cbpa.2026.102754_bib6","doi-asserted-by":"crossref","first-page":"1240","DOI":"10.1002\/jmri.21966","article-title":"Primer on gadolinium chemistry","volume":"30","author":"Sherry","year":"2009","journal-title":"J Magn Reson Imag"},{"key":"10.1016\/j.cbpa.2026.102754_bib7","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1097\/01.rli.0000197668.44926.f7","article-title":"Relaxivity of Gadopentetate Dimeglumine (Magnevist), Gadobutrol (Gadovist), and Gadobenate Dimeglumine (MultiHance) in human blood plasma at 0.2, 1.5, and 3 Tesla","volume":"41","author":"Pintaske","year":"2006","journal-title":"Investig Radiol"},{"key":"10.1016\/j.cbpa.2026.102754_bib8","doi-asserted-by":"crossref","DOI":"10.1186\/s41181-020-00107-8","article-title":"68Ga, 44Sc and 177Lu-labeled AAZTA(5)-PSMA-617: synthesis, radiolabeling, stability and cell binding compared to DOTA-PSMA-617 analogues","volume":"5","author":"Sinnes","year":"2020","journal-title":"EJNMMI Radiopharm. Chem."},{"key":"10.1016\/j.cbpa.2026.102754_bib9","doi-asserted-by":"crossref","first-page":"1339","DOI":"10.1007\/s00259-020-05057-6","article-title":"Extensive preclinical evaluation of lutetium-177-labeled PSMA-specific tracers for prostate cancer radionuclide therapy","volume":"48","author":"Ruigrok","year":"2021","journal-title":"Eur J Nucl Med Mol Imag"},{"key":"10.1016\/j.cbpa.2026.102754_bib10","doi-asserted-by":"crossref","first-page":"8600","DOI":"10.1021\/acs.jmedchem.3c00258","article-title":"Reduction of the renal radioactivity of 111In-DOTA-Labeled antibody fragments with a linkage cleaved by the renal brush border membrane enzymes","volume":"66","author":"Suzuki","year":"2023","journal-title":"J Med Chem"},{"key":"10.1016\/j.cbpa.2026.102754_bib11","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1007\/s00259-021-05564-0","article-title":"Combination of terbium-161 with somatostatin receptor antagonists-a potential paradigm shift for the treatment of neuroendocrine neoplasms","volume":"49","author":"Borgna","year":"2022","journal-title":"Eur J Nucl Med Mol Imag"},{"key":"10.1016\/j.cbpa.2026.102754_bib12","doi-asserted-by":"crossref","first-page":"1714","DOI":"10.1186\/s41181-024-00312-9","article-title":"First preclinical SPECT\/CT imaging and biodistribution of [165Er]ErCl3 and [165Er]Er-PSMA-617","volume":"9","author":"Saeedi Saghez","year":"2024","journal-title":"EJNMMI Radiopharm. Chem"},{"key":"10.1016\/j.cbpa.2026.102754_bib13","doi-asserted-by":"crossref","DOI":"10.2967\/jnumed.125.269601","article-title":"225Ac \u03b1-Pretargeted radioimmunotherapy of human epidermal growth factor receptor 2\u2013Expressing breast cancer","volume":"66","author":"Rinne","year":"2025","journal-title":"J Nucl Med"},{"key":"10.1016\/j.cbpa.2026.102754_bib14","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1016\/j.cbpa.2021.03.001","article-title":"Emerging chelators for nuclear imaging","volume":"63","author":"Sneddon","year":"2021","journal-title":"Curr Opin Chem Biol"},{"key":"10.1016\/j.cbpa.2026.102754_bib15","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1039\/C3CS60304K","article-title":"Matching chelators to radiometals for radiopharmaceuticals","volume":"43","author":"Price","year":"2014","journal-title":"Chem Soc Rev"},{"key":"10.1016\/j.cbpa.2026.102754_bib16","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1186\/s41181-023-00202-6","article-title":"The DOTA macrocyclic cavity in metallic radiopharmaceuticals: mythology or reality?","volume":"8","author":"Duatti","year":"2023","journal-title":"EJNMMI Radiopharm. Chem."},{"key":"10.1016\/j.cbpa.2026.102754_bib17","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1186\/s13550-017-0257-4","article-title":"44Sc-PSMA-617 for radiotheragnostics in tandem with 177Lu-PSMA-617\u2014preclinical investigations in comparison with 68Ga-PSMA-11 and 68Ga-PSMA-617","volume":"7","author":"Umbricht","year":"2017","journal-title":"EJNMMI Res"},{"key":"10.1016\/j.cbpa.2026.102754_bib18","doi-asserted-by":"crossref","DOI":"10.3389\/fchem.2024.1292566","article-title":"Exploration of commercial cyclen-based chelators for mercury-197 m\/g incorporation into theranostic radiopharmaceuticals","volume":"12","author":"Randhawa","year":"2024","journal-title":"Front Chem"},{"key":"10.1016\/j.cbpa.2026.102754_bib19","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-023-37313-8","article-title":"Optimized production, purification, and radiolabeling of the 203Pb\/212Pb theranostic pair for nuclear medicine","volume":"13","author":"McNeil","year":"2023","journal-title":"Sci Rep"},{"key":"10.1016\/j.cbpa.2026.102754_bib20","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1097\/COC.0000000000000353","article-title":"Safety and outcome measures of first-in-human intraperitoneal \u03b1 radioimmunotherapy with 212Pb-TCMC-Trastuzumab","volume":"41","author":"Meredith","year":"2018","journal-title":"Am J Clin Oncol"},{"key":"10.1016\/j.cbpa.2026.102754_bib21","doi-asserted-by":"crossref","first-page":"22159","DOI":"10.1021\/acs.inorgchem.5c04291","article-title":"Carboxylic- and amide donor-functionalized Pyridine-N-trans-Substituted cyclen-based chelators for 203Pb\/212Pb theranostic radiopharmaceuticals","volume":"64","author":"Mastroianni","year":"2025","journal-title":"Inorg Chem"},{"key":"10.1016\/j.cbpa.2026.102754_sref22","doi-asserted-by":"crossref","first-page":"19468","DOI":"10.1021\/acs.inorgchem.4c03571","article-title":"Radiochemistry and complex formation of the cyclen-derived chelator DOTI-Me with Mn2+, Cu2+, Zn2+, Ga3+, In3+, Tb3+, and Lu3+","volume":"63","author":"Hierlmeier","year":"2024","journal-title":"Inorg Chem"},{"key":"10.1016\/j.cbpa.2026.102754_bib23","doi-asserted-by":"crossref","first-page":"5371","DOI":"10.7150\/thno.100091","article-title":"The heterobivalent (SSTR2\/albumin) radioligand [67Cu]Cu-NODAGA-cLAB4-TATE enables efficient somatostatin receptor radionuclide theranostics","volume":"14","author":"Ullrich","year":"2024","journal-title":"Theranostics"},{"key":"10.1016\/j.cbpa.2026.102754_bib24","doi-asserted-by":"crossref","DOI":"10.1002\/anie.202412357","article-title":"Controlling the redox chemistry of cobalt radiopharmaceuticals","volume":"63","author":"Lin","year":"2024","journal-title":"Angew Chem Int Ed"},{"key":"10.1016\/j.cbpa.2026.102754_bib25","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1007\/s11307-024-01973-3","article-title":"First-in-human evaluation of safety and dosimetry of [64Cu]FBP8: a fibrin-binding PET probe","volume":"27","author":"Izquierdo-Garcia","year":"2025","journal-title":"Mol Imag Biol"},{"issue":"Suppl. 1","key":"10.1016\/j.cbpa.2026.102754_sref26","article-title":"A phase 1 trial of 61Cu-NODAGA-PSMA I& T for patients with prostate cancer","volume":"66","author":"Ulaner","year":"2025","journal-title":"J Nucl Med"},{"key":"10.1016\/j.cbpa.2026.102754_bib27","article-title":"67Cu-SARTATE\u2122 peptide receptor radionuclide therapy administered to pediatric patients with high-risk neuroblastoma: a multi-center, dose-escalation, open-label, non-randomized, phase 1-2a theranostic clinical trial","year":"2019","journal-title":"ClinicalTrials.gov Identifier: NCT04023331"},{"key":"10.1016\/j.cbpa.2026.102754_bib28","doi-asserted-by":"crossref","first-page":"20634","DOI":"10.1021\/acs.inorgchem.3c01417","article-title":"H3nota derivatives possessing picolyl and picolinate pendants for Ga3+ coordination and 67Ga3+ radiolabeling","volume":"62","author":"Marlin","year":"2023","journal-title":"Inorg Chem"},{"key":"10.1016\/j.cbpa.2026.102754_bib29","doi-asserted-by":"crossref","first-page":"4511","DOI":"10.1021\/acs.molpharmaceut.1c00711","article-title":"Evaluation of 177Lu and 47Sc Picaga-linked, prostate-specific membrane antigen-targeting constructs for their radiotherapeutic efficacy and dosimetry","volume":"18","author":"Vaughn","year":"2021","journal-title":"Mol Pharm"},{"key":"10.1016\/j.cbpa.2026.102754_bib30","doi-asserted-by":"crossref","first-page":"1232","DOI":"10.1021\/acs.bioconjchem.0c00574","article-title":"Homologous structural, chemical, and biological behavior of Sc and Lu complexes of the Picaga bifunctional chelator: toward development of matched Theranostic pairs for radiopharmaceutical applications","volume":"32","author":"Vaughn","year":"2021","journal-title":"Bioconjug Chem"},{"key":"10.1016\/j.cbpa.2026.102754_sref31","doi-asserted-by":"crossref","first-page":"33121","DOI":"10.1021\/jacs.4c11254","article-title":"Phosphonate-based Aza-Macrocycle ligands for low-temperature, stable chelation of medicinally relevant rare Earth radiometals and radiofluorination","volume":"146","author":"Whetter","year":"2024","journal-title":"J Am Chem Soc"},{"key":"10.1016\/j.cbpa.2026.102754_bib32","doi-asserted-by":"crossref","first-page":"20699","DOI":"10.1021\/acs.inorgchem.3c01983","article-title":"Equilibrium thermodynamics of macropa complexes with selected metal isotopes of radiopharmaceutical interest","volume":"62","author":"Blei","year":"2023","journal-title":"Inorg Chem"},{"key":"10.1016\/j.cbpa.2026.102754_bib33","doi-asserted-by":"crossref","first-page":"3331","DOI":"10.1021\/ja808534w","article-title":"Macrocyclic receptor exhibiting unprecedented selectivity for light lanthanides","volume":"131","author":"Roca-Sabio","year":"2009","journal-title":"J Am Chem Soc"},{"key":"10.1016\/j.cbpa.2026.102754_bib34","year":"2023","journal-title":"ClinicalTrials.gov Identifier: NCT06052306"},{"key":"10.1016\/j.cbpa.2026.102754_bib35","doi-asserted-by":"crossref","first-page":"22422","DOI":"10.1021\/acs.inorgchem.5c03908","article-title":"Heavy alkaline Earth radiometals for cancer theranostics: coordination and radiochemistry of Radium-223 and Barium-131 with Kryptofix 22-Based chelators","volume":"64","author":"Franchi","year":"2025","journal-title":"Inorg Chem"},{"key":"10.1016\/j.cbpa.2026.102754_bib36","doi-asserted-by":"crossref","first-page":"21177","DOI":"10.1021\/acs.inorgchem.4c03498","article-title":"The H2Sxmacropa series: increasing the chemical softness of H2macropa with sulfur atoms to chelate radiometals [213Bi]Bi3+ and [203Pb]Pb2+ for radiopharmaceutical applications","volume":"63","author":"Randhawa","year":"2024","journal-title":"Inorg Chem"},{"key":"10.1016\/j.cbpa.2026.102754_bib37","doi-asserted-by":"crossref","first-page":"14634","DOI":"10.1039\/D4DT02146K","article-title":"Chelation of [111In]In3+ with the dual-size-selective macrocycles py-macrodipa and py2-macrodipa","volume":"53","author":"Lee","year":"2024","journal-title":"Dalton Trans"},{"key":"10.1016\/j.cbpa.2026.102754_bib38","doi-asserted-by":"crossref","first-page":"10429","DOI":"10.1021\/jacs.1c05339","article-title":"Py-Macrodipa: a janus chelator capable of binding medicinally relevant rare-earth radiometals of disparate sizes","volume":"143","author":"Hu","year":"2021","journal-title":"J Am Chem Soc"},{"key":"10.1016\/j.cbpa.2026.102754_bib39","doi-asserted-by":"crossref","DOI":"10.1002\/ejic.202300457","article-title":"Construction of the bioconjugate Py-Macrodipa-PSMA and its in vivo investigations with large (132\/135La3+) and small (47Sc3+) radiometal ions","volume":"26","author":"Hu","year":"2023","journal-title":"Eur J Inorg Chem"},{"key":"10.1016\/j.cbpa.2026.102754_bib40","doi-asserted-by":"crossref","first-page":"13911","DOI":"10.1021\/acs.inorgchem.4c01180","article-title":"H3trica: versatile macrocyclic Chelator for [225Ac]Ac3+ and [155\/161Tb]Tb3+ theranostics","volume":"63","author":"Fiaccabrino","year":"2024","journal-title":"Inorg Chem"},{"key":"10.1016\/j.cbpa.2026.102754_bib41","doi-asserted-by":"crossref","first-page":"11801","DOI":"10.1039\/D5DT01103E","article-title":"Evaluating a triaza-18-crown-6 picolinate chelator for [212\/203Pb]Pb2+ and [212\/213Bi]Bi3+ theranostics","volume":"54","author":"Fiaccabrino","year":"2025","journal-title":"Dalton Trans"},{"key":"10.1016\/j.cbpa.2026.102754_bib42","article-title":"Preclinical evaluation of MC1R targeting theranostic pair [155Tb]Tb-crown-\u03b1MSH and [161Tb]Tb-crown-\u03b1MSH","volume":"136\u2013137","author":"Wharton","year":"2024","journal-title":"Nucl Med Biol"},{"key":"10.1016\/j.cbpa.2026.102754_bib43","first-page":"11435","article-title":"Synthesis and evaluation of a macrocyclic Actinium-225 Chelator, quality control and in vivo evaluation of 225Ac-crown-\u03b1MSH peptide. Chem. Eur","volume":"26","author":"Yang","year":"2020"},{"key":"10.1016\/j.cbpa.2026.102754_bib44","series-title":"Elucirem NDA 216986\/S-005 approval letter","year":"2024"},{"key":"10.1016\/j.cbpa.2026.102754_bib45","doi-asserted-by":"crossref","DOI":"10.1002\/chem.202403358","article-title":"Bifunctional hexadentate Pyclen\u2013Based chelating agent for mild radiofluorination in aqueous solution at room temperature with a Ga-18F ternary complex","volume":"30","author":"Dioury","year":"2024","journal-title":"Chem Eur J"},{"key":"10.1016\/j.cbpa.2026.102754_bib46","doi-asserted-by":"crossref","DOI":"10.1002\/chem.202502763","article-title":"Sc(III) complexes of Pyclen derivative ligands as probes for hypoxia: synthesis, chemical characterization, 44Sc-Radiolabeling, and preclinical assessment","volume":"31","author":"Csup\u00e1sz","year":"2025","journal-title":"Chem Eur J"},{"key":"10.1016\/j.cbpa.2026.102754_bib47","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1021\/mp400686z","article-title":"Pycup\u2014A bifunctional, cage-like ligand for 64Cu radiolabeling","volume":"11","author":"Boros","year":"2014","journal-title":"Mol Pharm"},{"key":"10.1016\/j.cbpa.2026.102754_sref48","doi-asserted-by":"crossref","first-page":"11279","DOI":"10.1039\/D3SC06854D","article-title":"PYTA: a universal chelator for advancing the theranostic palette of nuclear medicine","volume":"15","author":"Simms","year":"2024","journal-title":"Chem Sci"},{"key":"10.1016\/j.cbpa.2026.102754_sref49","doi-asserted-by":"crossref","first-page":"1396","DOI":"10.2967\/jnumed.125.270234","article-title":"Versatile bifunctional PYTA derivatives for 225Ac radiolabeling: a comparison to gold standards","volume":"66","author":"Cheveau","year":"2025","journal-title":"J Nucl Med"},{"key":"10.1016\/j.cbpa.2026.102754_bib50","doi-asserted-by":"crossref","first-page":"1070","DOI":"10.1039\/D3QI02354K","article-title":"Exploring the use of rigid 18-membered macrocycles with amide pendant arms for pb(ii)-based radiopharmaceuticals","volume":"11","author":"Harriswangler","year":"2024","journal-title":"Inorg Chem Front"},{"key":"10.1016\/j.cbpa.2026.102754_bib51","doi-asserted-by":"crossref","first-page":"1856","DOI":"10.1039\/D4MD00591K","article-title":"Enhancing the radionuclide theranostic concept through the radiohybrid approach","volume":"16","author":"Kr\u00f6nke","year":"2025","journal-title":"RSC Med Chem"},{"key":"10.1016\/j.cbpa.2026.102754_bib52","doi-asserted-by":"crossref","first-page":"735","DOI":"10.2967\/jnumed.119.234922","article-title":"Radiohybrid ligands: a novel tracer concept exemplified by 18F- or 68Ga-Labeled rhPSMA inhibitors","volume":"61","author":"Wurzer","year":"2020","journal-title":"J Nucl Med"},{"key":"10.1016\/j.cbpa.2026.102754_bib53","doi-asserted-by":"crossref","first-page":"11940","DOI":"10.1039\/D4CC04165H","article-title":"Fluorine-18 incorporation and radiometal coordination in macropa ligands for PET imaging and targeted alpha therapy","volume":"60","author":"Kanagasundaram","year":"2024","journal-title":"Chem Commun"},{"key":"10.1016\/j.cbpa.2026.102754_bib54","article-title":"A macrocyclic hybrid PET\/MRI probe for quantitative perfusion imaging in vivo","volume":"63","author":"Kretschmer","year":"2024","journal-title":"Angew Chem Int Ed"},{"key":"10.1016\/j.cbpa.2026.102754_bib55","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1186\/s41824-026-00295-7","article-title":"The analysis of biodistribution and tumor uptake of [18F]AlF-FAPI-74 in patients with soft tissue sarcoma and gastro-intestinal tumors compared with [18F]FDG in a prospective, exploratory study","volume":"10","author":"Novruzov","year":"2026","journal-title":"EJNMMI Rep"},{"key":"10.1016\/j.cbpa.2026.102754_bib56","doi-asserted-by":"crossref","first-page":"21834","DOI":"10.1021\/acs.inorgchem.5c02261","article-title":"A comprehensive study of the Sc(III)\u2013OPC2A\u2013Fluoride interaction: equilibrium, kinetics, and 44Sc-Labeling","volume":"64","author":"Dahman","year":"2025","journal-title":"Inorg Chem"},{"key":"10.1016\/j.cbpa.2026.102754_sref57","doi-asserted-by":"crossref","first-page":"26234","DOI":"10.1021\/acs.jmedchem.5c02286","article-title":"Evaluation of bifunctional, PSMA-targeted Triazamacrocycle-Picolinates compatible with the 18F\/44Sc\/177Lu isotope triad","volume":"68","author":"Glaser","year":"2025","journal-title":"J Med Chem"},{"key":"10.1016\/j.cbpa.2026.102754_bib58","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1021\/acs.chemrev.8b00281","article-title":"Radioactive transition metals for imaging and therapy","volume":"119","author":"Boros","year":"2019","journal-title":"Chem Rev"},{"key":"10.1016\/j.cbpa.2026.102754_bib59","first-page":"1271","article-title":"89Zr immuno-PET: comprehensive procedures for the production of 89Zr-labeled monoclonal antibodies","volume":"44","author":"Verel","year":"2003","journal-title":"J Nucl Med"},{"key":"10.1016\/j.cbpa.2026.102754_bib60","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.2967\/jnumed.110.076174","article-title":"89Zr-DFO-J591 for ImmunoPET of prostate-specific membrane antigen expression in vivo","volume":"51","author":"Holland","year":"2010","journal-title":"J Nucl Med"},{"key":"10.1016\/j.cbpa.2026.102754_bib61","doi-asserted-by":"crossref","first-page":"4849","DOI":"10.1021\/jm500389b","article-title":"Alternative chelator for 89Zr radiopharmaceuticals: radiolabeling and evaluation of 3,4,3-(LI-1,2-HOPO)","volume":"57","author":"Deri","year":"2014","journal-title":"J Med Chem"},{"key":"10.1016\/j.cbpa.2026.102754_bib62","doi-asserted-by":"crossref","first-page":"8805","DOI":"10.1021\/ic4010246","article-title":"Solution thermodynamic stability of complexes formed with the octadentate hydroxypyridinonate ligand 3,4,3-LI(1,2-HOPO): a critical feature for efficient chelation of Lanthanide(IV) and Actinide(IV) ions","volume":"52","author":"Deblonde","year":"2013","journal-title":"Inorg Chem"},{"key":"10.1016\/j.cbpa.2026.102754_bib63","doi-asserted-by":"crossref","first-page":"16772","DOI":"10.1039\/D5DT01312G","article-title":"Investigation and preparation of a TREN-based bifunctional chelator for 89Zr","volume":"54","author":"Lucero","year":"2025","journal-title":"Dalton Trans"},{"key":"10.1016\/j.cbpa.2026.102754_bib64","doi-asserted-by":"crossref","DOI":"10.1002\/anie.202423878","article-title":"Towards the stable chelation of Radioantimony(V) for targeted auger theranostics","volume":"64","author":"Olson","year":"2025","journal-title":"Angew Chem Int Ed"},{"key":"10.1016\/j.cbpa.2026.102754_bib65","doi-asserted-by":"crossref","first-page":"2579","DOI":"10.1021\/acs.bioconjchem.5b00572","article-title":"p-SCN-Bn-HOPO: a superior bifunctional chelator for 89Zr ImmunoPET","volume":"26","author":"Deri","year":"2015","journal-title":"Bioconjug Chem"},{"key":"10.1016\/j.cbpa.2026.102754_bib66","doi-asserted-by":"crossref","first-page":"20013","DOI":"10.1021\/acs.inorgchem.5c02471","article-title":"Photodecarboxylation of the siderophore aerobactin with the lewis acidic metal ions Fe(III), Ga(III), and Ti(IV)","volume":"64","author":"Amason","year":"2025","journal-title":"Inorg Chem"},{"key":"10.1016\/j.cbpa.2026.102754_bib67","doi-asserted-by":"crossref","first-page":"2618","DOI":"10.1007\/s00259-022-05750-8","article-title":"Design, synthesis, and preclinical evaluation of a novel bifunctional macrocyclic chelator for theranostics of cancers","volume":"49","author":"Xu","year":"2022","journal-title":"Eur J Nucl Med Mol Imag"},{"key":"10.1016\/j.cbpa.2026.102754_bib68","doi-asserted-by":"crossref","first-page":"20567","DOI":"10.1021\/acs.inorgchem.2c03931","article-title":"Sc-HOPO: a potential construct for use in Radioscandium-Based radiopharmaceuticals","volume":"62","author":"Phipps","year":"2023","journal-title":"Inorg Chem"},{"key":"10.1016\/j.cbpa.2026.102754_sref69","doi-asserted-by":"crossref","DOI":"10.1002\/anie.202319578","article-title":"\u201cOff-Label Use\u201d of the Siderophore enterobactin enables targeted imaging of cancer with radioactive Ti(IV)","volume":"63","author":"Koller","year":"2024","journal-title":"Angew Chem Int Ed"},{"key":"10.1016\/j.cbpa.2026.102754_bib70","doi-asserted-by":"crossref","first-page":"1622","DOI":"10.1021\/ic00257a030","article-title":"Ferric ion sequestering agents. 15. Synthesis, solution chemistry, and electrochemistry of a new cationic analog of enterobactin","volume":"26","author":"Rodgers","year":"1987","journal-title":"Inorg Chem"},{"key":"10.1016\/j.cbpa.2026.102754_bib71","doi-asserted-by":"crossref","first-page":"12025","DOI":"10.1021\/acs.inorgchem.0c00975","article-title":"Catechol-based functionalizable ligands for Gallium-68 positron emission tomography imaging","volume":"59","author":"Joaqui-Joaqui","year":"2020","journal-title":"Inorg Chem"},{"key":"10.1016\/j.cbpa.2026.102754_bib72","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1021\/acs.bioconjchem.5c00099","article-title":"Evaluation of PSMA-targeted TREN-CAM conjugates for targeted imaging of cancer with 68Ga(III) and 45Ti(IV)","volume":"36","author":"Marlin","year":"2025","journal-title":"Bioconjug Chem"},{"key":"10.1016\/j.cbpa.2026.102754_bib73","doi-asserted-by":"crossref","DOI":"10.1016\/j.jinorgbio.2025.113077","article-title":"Synthesis and evaluation of HOPO-O8-Methyl-tetrazine as a bifunctional chelator for use in [89Zr]Zr4+, [161Tb]Tb3+ and [227Th]Th4+ radioimmunoconjugates","volume":"274","author":"Carbo-Bague","year":"2026","journal-title":"J Inorg Biochem"},{"key":"10.1016\/j.cbpa.2026.102754_bib74","doi-asserted-by":"crossref","first-page":"1682","DOI":"10.1021\/acs.jmedchem.4c02423","article-title":"Synthesis and evaluation of a bifunctional chelator for Thorium-227 targeted radiotherapy","volume":"68","author":"Woods","year":"2025","journal-title":"J Med Chem"},{"key":"10.1016\/j.cbpa.2026.102754_sref75","doi-asserted-by":"crossref","first-page":"1435","DOI":"10.2967\/jnumed.124.267667","article-title":"Single chelator\u2013minibody Theranostic agents for 89Zr PET imaging and 177Lu radiopharmaceutical therapy of PSMA-expressing prostate cancer","volume":"65","author":"Ho","year":"2024","journal-title":"J Nucl Med"},{"key":"10.1016\/j.cbpa.2026.102754_bib76","doi-asserted-by":"crossref","first-page":"3787","DOI":"10.1021\/acs.chemrev.9b00738","article-title":"ImmunoPET: concept, design, and applications","volume":"120","author":"Wei","year":"2020","journal-title":"Chem Rev"},{"key":"10.1016\/j.cbpa.2026.102754_bib77","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1038\/s44303-025-00126-7","article-title":"New insights into radiolabelled siderophores for molecular imaging of bacterial infections","volume":"3","author":"Dvorakova Bendova","year":"2025","journal-title":"npj Imaging"},{"key":"10.1016\/j.cbpa.2026.102754_bib78","doi-asserted-by":"crossref","first-page":"9872","DOI":"10.1039\/C4DT00733F","article-title":"Charting the mechanism and reactivity of zirconium oxalate with hydroxamate ligands using density functional theory: implications in new chelate design","volume":"43","author":"Holland","year":"2014","journal-title":"Dalton Trans"},{"key":"10.1016\/j.cbpa.2026.102754_bib79","article-title":"Radiolabeling of CHX-A\u2033-DTPA-Antibody conjugates with [89Zr]ZrCl4","volume":"125","author":"Lyashchenko","year":"2025","journal-title":"J Nucl Med"},{"key":"10.1016\/j.cbpa.2026.102754_bib80","doi-asserted-by":"crossref","first-page":"17443","DOI":"10.1021\/acs.inorgchem.0c02725","article-title":"Structural characterization of the solution chemistry of Zirconium(IV) desferrioxamine: a coordination sphere completed by hydroxides","volume":"59","author":"Summers","year":"2020","journal-title":"Inorg Chem"},{"key":"10.1016\/j.cbpa.2026.102754_bib81","doi-asserted-by":"crossref","first-page":"11523","DOI":"10.1039\/C4CC05558F","article-title":"An octadentate bifunctional chelating agent for the development of stable zirconium-89 based molecular imaging probes","volume":"50","author":"Patra","year":"2014","journal-title":"Chem Commun"},{"key":"10.1016\/j.cbpa.2026.102754_bib82","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1007\/s00775-020-01800-4","article-title":"Radiolabelling of the octadentate chelators DFO\u2217 and oxoDFO\u2217 with zirconium-89 and gallium-68","volume":"25","author":"Brandt","year":"2020","journal-title":"J Biol Inorg Chem"},{"key":"10.1016\/j.cbpa.2026.102754_bib83","doi-asserted-by":"crossref","DOI":"10.1002\/cmdc.202400890","article-title":"Isopeptidic desferrioxamine analogues: the role of hydroxamate spacing for chelation of Zr4+","volume":"20","author":"Outzen","year":"2025","journal-title":"ChemMedChem"}],"container-title":["Current Opinion in Chemical Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1367593126001031?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1367593126001031?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T20:34:37Z","timestamp":1788986077000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1367593126001031"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10]]},"references-count":83,"alternative-id":["S1367593126001031"],"URL":"https:\/\/doi.org\/10.1016\/j.cbpa.2026.102754","relation":{},"ISSN":["1367-5931"],"issn-type":[{"value":"1367-5931","type":"print"}],"subject":[],"published":{"date-parts":[[2026,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Recent advancements in radiometal chelation for targeted applications in nuclear medicine","name":"articletitle","label":"Article Title"},{"value":"Current Opinion in Chemical Biology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cbpa.2026.102754","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"102754"}}